KR20200005217A - An anti-drunkenness and hangover-alleviating composition and its preparation method - Google Patents
An anti-drunkenness and hangover-alleviating composition and its preparation method Download PDFInfo
- Publication number
- KR20200005217A KR20200005217A KR1020180078663A KR20180078663A KR20200005217A KR 20200005217 A KR20200005217 A KR 20200005217A KR 1020180078663 A KR1020180078663 A KR 1020180078663A KR 20180078663 A KR20180078663 A KR 20180078663A KR 20200005217 A KR20200005217 A KR 20200005217A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- total flavanone
- total
- dogwood
- hangover
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title description 5
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 claims abstract description 68
- 235000011981 flavanones Nutrition 0.000 claims abstract description 68
- 229930003949 flavanone Natural products 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 9
- 244000167230 Lonicera japonica Species 0.000 claims abstract description 3
- 235000017617 Lonicera japonica Nutrition 0.000 claims abstract description 3
- 150000002207 flavanone derivatives Chemical class 0.000 claims abstract 23
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 241000209020 Cornus Species 0.000 claims description 28
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 16
- 229910052698 phosphorus Inorganic materials 0.000 claims description 15
- 239000011574 phosphorus Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 14
- 230000002265 prevention Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229920000858 Cyclodextrin Polymers 0.000 claims description 10
- 239000001116 FEMA 4028 Substances 0.000 claims description 10
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 10
- 229960004853 betadex Drugs 0.000 claims description 10
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000003801 milling Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 235000019202 steviosides Nutrition 0.000 claims description 6
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 238000004440 column chromatography Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000001953 recrystallisation Methods 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000002075 main ingredient Substances 0.000 claims description 2
- 235000013334 alcoholic beverage Nutrition 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 241000864415 Cornus controversa Species 0.000 abstract 1
- 150000002208 flavanones Chemical class 0.000 description 43
- 235000019441 ethanol Nutrition 0.000 description 28
- 230000035622 drinking Effects 0.000 description 22
- 208000002173 dizziness Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000013405 beer Nutrition 0.000 description 4
- 230000035987 intoxication Effects 0.000 description 4
- 231100000566 intoxication Toxicity 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 235000020097 white wine Nutrition 0.000 description 4
- 206010001605 Alcohol poisoning Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010053164 Alcohol withdrawal syndrome Diseases 0.000 description 2
- 208000029650 alcohol withdrawal Diseases 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001570521 Lonicera periclymenum Species 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 의약 분야, 특히 주취 예방 및 숙취 해소 작용을 갖는 조성물 및 그의 제조 방법에 관한 것이다.FIELD OF THE INVENTION The present invention relates to the pharmaceutical field, and in particular to compositions having a odor preventing and hangover relieving action and methods for their preparation.
적절한 음주는 인체의 건강에 도움을 준다. 그러나, 지나친 음주는 음주 후 주취 및, 현기증, 두통, 숙취 및 비행의 발생을 야기할 수 있으며, 정상의 근무 및 대인간의 소통에 영향을 미친다. 또한 더욱 심각한 것은 지나친 음주가 신체 조직 및 장기를 손상시킬 수 있다는 점이다. 예를 들면, 지속적인 지나친 음주는 간 세포를 손상시킬 수 있으며, 간의 정상적인 대사를 방해하며, 알콜성 간염 및 경변증을 추가로 유발한다. 게다가, 빈번한 음주는 알콜 의존성을 야기할 수 있으며, 다시 말하자면 음주를 갑자기 중단하거나 또는 알콜 소비를 줄인 후의 다양한 불쾌한 신체 증상이 나타날 것이며, 이는 또한 알콜 금단 증후군으로 알려져 있다.Proper drinking can help your health. However, excessive drinking can lead to the occurrence of alcohol and dizziness, headaches, hangovers and misdeeds after drinking and affect normal work and interpersonal communication. More seriously, excessive drinking can damage body tissues and organs. For example, excessive excessive drinking can damage liver cells, interfere with normal metabolism of the liver, and further cause alcoholic hepatitis and cirrhosis. In addition, frequent drinking may lead to alcohol dependence, that is, various unpleasant physical symptoms after sudden stop drinking or reducing alcohol consumption will also occur, which is also known as alcohol withdrawal syndrome.
그러므로, 사람들은 음주에 의하여 야기되는 불쾌감을 해소하는 다양한 방법을 채택하며, 시장에는 해당 판매 중인 제품이 다수 존재한다. 그러나 대부분의 제품은 부정확한 치료 효과를 갖는다.Therefore, people adopt various methods to solve the discomfort caused by drinking, and there are many products on sale in the market. However, most products have inaccurate therapeutic effects.
상기 문제점을 해결하기 위하여, 본 발명은 다수의 실험에 기초하여 신규한 주취 예방 및 숙취 해소 조성물을 제안한다. 그러한 조성물은 음주자의 주취 한계치를 상당하게 개선시킬 수 있으며, 주취 및 주취에 의하여 야기되는 신체 불쾌감, 예컨대 현기증, 통제 불능의 행동 등을 예방하며, 대상체의 알콜 금단 증후군을 완화시킨다. 게다가, 그러한 조성물은 알콜의 분해를 촉진시키며 간 세포에 대한 알콜의 손상을 완화시킬 수 있는 간 보호 성분을 포함하여, 이상적인 주취 예방 및 숙취 해소 제품이 된다.In order to solve the above problems, the present invention proposes a novel alcohol prevention and hangover composition based on a number of experiments. Such compositions can significantly improve the alcohol intoxication threshold, prevent bodily discomfort caused by alcohol and intoxication such as dizziness, uncontrollable behavior, and alleviate the subject's alcohol withdrawal syndrome. In addition, such compositions include liver protection ingredients that can accelerate the breakdown of alcohol and mitigate alcohol damage to liver cells, making it an ideal anti-drinking and hangover product.
상기 기술적 목적을 달성하기 위하여, 본 발명은 하기 기술적 해결책을 채택한다:In order to achieve the above technical object, the present invention adopts the following technical solution:
인동(Lonicera japonica)의 총 플라바논(total flavanone) 추출물, 파키만(Pachyman)의 총 플라바논 추출물 및 층층나무(Dogwood)의 총 플라바논 추출물로부터 선택된 1종 이상을 포함하는 주성분을 함유하는 주취 예방 및 숙취 해소 조성물.Prevention of intoxication containing a main ingredient comprising at least one selected from total flavanone extract of Lonicera japonica, total flavanone extract of Pachyman and total flavanone extract of Dogwood And hangover relief compositions.
바람직하게는, 중량부로 인동의 총 플라바논 추출물 0-40, 파키만의 총 플라바논 추출물 0-40 및 층층나무의 총 플라바논 추출물 20-100을 포함하는 주성분.Preferably, the main component comprises a total flavanone extract 0-40 of Phosphorus by weight, a total flavanone extract 0-40 of Pachyman and a total flavanone extract 20-100 of Dogwood.
바람직하게는, 인동의 총 플라바논 추출물 중의 총 플라바논 함유량은 >50%이며, 파키만의 총 플라바논 추출물 중의 총 플라바논 함유량은 >80%이며, 층층나무의 총 플라바논 추출물 중의 총 플라바논 함유량은 >80%이다.Preferably, the total flavanone content in the total flavanone extract of Phosphorus is> 50%, the total flavanone content in the total flavanone extract of Pakiman is> 80%, and the total flavanone in the total flavanone extract of the dogwood The content is> 80%.
인동의 총 플라바논 추출물, 파키만의 총 플라바논 추출물 및 층층나무의 총 플라바논 추출물은 하기 방법에 의해 제조된다: 인동, 파키만 및 층층나무를 분쇄하고; 분쇄한 생성물을 물 또는 70% 미만의 농도인 에탄올로 각각 추출하며; 추출된 용액을 회수하고; 원심분리하고; 추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조시키고; 각각의 추출물의 함유량이 요건을 충족하는지를 확인하기 위하여 검출한다.Total flavanone extract of honeysuckle, total flavanone extract of pachyman and total flavanone extract of dogwood are prepared by the following method: grinding the phosphorus, pachyman and dogwood; The milled products were each extracted with water or ethanol at a concentration of less than 70%; Recover the extracted solution; Centrifugation; Extraction, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; Detection is made to ensure that the content of each extract meets the requirements.
본 발명의 주취 예방 및 숙취 해소 조성물은 β-시클로덱스트린, 말토덱스트린 및 스테비오사이드로부터 선택된 1종 이상을 포함하는 아주반트(adjuvant) 성분을 더 포함한다. The alcohol prevention and hangover composition of the present invention further comprises an adjuvant component comprising at least one selected from β-cyclodextrin, maltodextrin and stevioside.
바람직하게는, 주성분 및 아주반트 성분의 중량비는 1:(0-3)이다.Preferably, the weight ratio of the main component and the adjuvant component is 1: (0-3).
본 발명은 또한 하기 단계를 포함하는 주취 예방 및 숙취 해소 조성물의 제조방법을 개시한다. The present invention also discloses a process for the preparation of a hangover prevention and hangover relief composition comprising the following steps.
(1) 인동, 파키만 및 층층나무를 분쇄하고; 분쇄된 생성물을 물 또는 70% 미만의 농도인 에탄올로 각각 추출하고; 추출된 용액을 회수하고; 원심분리하고; 추출, 침강, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조시키고; 각각의 추출물의 함유량이 요건을 충족하는지를 확인하기 위하여 검출하여 인동의 총 플라바논 추출물, 파키만의 총 플라바논 추출물 및 층층나무의 총 플라바논 추출물을 얻고; 각각의 추출물을 분쇄하고, 60-메쉬 체로 체질하는 단계;(1) grinding copper, pachyman and dogwood; The milled product was each extracted with water or ethanol at a concentration of less than 70%; Recover the extracted solution; Centrifugation; Extraction, settling, macroporous resin column chromatography or recrystallization; Vacuum dried at 40-50 ° C .; Detecting to obtain that the content of each extract meets the requirements to obtain a total flavanone extract of phosphorus, a total flavanone extract of pakiman and a total flavanone extract of dogwood; Milling each extract and sieving with a 60-mesh sieve;
(2) 중량부로 인동의 총 플라바논 추출물 0-40, 파키만의 총 플라바논 추출물 0-40 및 층층나무의 총 플라바논 추출물 20-100을 계량하고, 이를 균일하게 혼합하여 주성분을 얻는 단계;(2) weighing the total flavanone extract 0-40 of Phosphorus, the total flavanone extract 0-40 of Pakiman and the total flavanone extract 20-100 of the dogwood by weight, and mixing them uniformly to obtain a main component;
(3) 중량부로 β-시클로덱스트린 0-100 및 말토덱스트린 0-100을 계량하고, 이를 주성분과 균일하게 혼합하고, 총 중량을 기준으로 하여 10-50% 물을 첨가하고, 반복적으로 제분, 진공 건조, 분쇄 및 60-메쉬 체를 사용한 체질을 실시하는 단계; 및(3) Weigh out β-cyclodextrin 0-100 and maltodextrin 0-100 by weight, mix it uniformly with the main component, add 10-50% water based on the total weight, repeat milling, vacuum Drying, grinding and sieving with a 60-mesh sieve; And
(4) 0-20 중량부의 스테비오사이드를 첨가하고, 균일하게 혼합, 살균, 펠릿화하여 캡슐, 정제 또는 지제(electuary)로 제조하는 단계. (4) adding 0-20 parts by weight of stevioside, uniformly mixing, sterilizing and pelletizing to prepare into capsules, tablets or electuary.
본 발명에 기재된 주취 예방 및 숙취 해소 조성물은 층층나무를 주성분으로서 포함하며, 인동 및 층층나무를 아주반트 성분으로서 포함한다. 지원자에 대한 효과의 관찰에 기초하여 주취 예방 및 숙취 해소 조성물은 주취 한계치를 개선시키고, 주취 증후군을 완화 또는 감소시키는 효과를 갖는 것으로 입증되었다.The alcohol-prevention and hangover-resolving composition described in this invention contains dogwood as a main component, and phosphorus and dogwood as an adjuvant component. Based on the observation of the effect on the volunteers, the alcohol-induced and hang-over composition has been proven to have an effect of improving the alcohol threshold and alleviating or reducing alcohol syndrome.
이하, 본 발명은 구체적인 예와 조합하여 추가로 기재될 것이지만, 본 발명은 그러한 예에 한정되지 않을 것이다.Hereinafter, the present invention will be further described in combination with specific examples, but the present invention will not be limited to such examples.
실시예Example 1 One
인동의Human 총 gun 플라바논Flavanon 추출물, extract, 파키만의Pakiman 총 gun 플라바논Flavanon 추출물 및 층층나무의 총 플라바논 추출물의 제조 Preparation and Preparation of Total Flavanone Extract of Dogwood
목표 인동의 총 플라바논 추출물은 인동을 분쇄하고; 분쇄된 인동을 60% 에탄올로 환류 가열 추출하고; 추출된 용액을 회수하고; 원심분리하고; 상청액을 수집하고, 거대다공성 수지 컬럼 크로마토그래피를 수행하여 총 플라바논 농축 부분을 얻고; 용매를 회수하고; 원심분리하고; 40-50℃에서 진공 건조시키고; 총 플라바논 함유량이 >50%이라는 것을 확인하기 위하여 검출하여 생성된다.Total flavanone extract of the target phosphorus crushes the phosphorus; The ground phosphor was extracted by reflux with 60% ethanol; Recover the extracted solution; Centrifugation; The supernatant was collected and subjected to macroporous resin column chromatography to obtain a total flavanone enriched portion; Recover the solvent; Centrifugation; Vacuum dried at 40-50 ° C .; Detected to produce a total flavanone content of> 50%.
목표 파키만의 총 플라바논 추출물은 파키만을 분쇄하고; 분쇄된 파키만을 40% 에탄올로 초음파 추출하고; 추출된 용액을 회수하고; 원심분리하고; 상청액을 수집하고; 추출을 에틸 아세테이트로 수행하여 총 플라바논 농축 부분을 얻고; 용매를 회수하고; 농축시키고; 40-50℃에서 진공 건조시키고; 총 플라바논 함유량이 >80%인지를 확인하기 위하여 검출하여 생성된다.Total flavanone extract of target pachyman pulverizes pachyman; Only the pulverized paki was extracted with 40% ethanol; Recover the extracted solution; Centrifugation; Collect the supernatant; Extraction is performed with ethyl acetate to obtain a total flavanone concentrated portion; Recover the solvent; Concentrated; Vacuum dried at 40-50 ° C .; Detected to produce a total flavanone content of> 80%.
목표 층층나무의 총 플라바논 추출물은 층층나무를 분쇄하고; 분쇄된 층층나무를 60% 에탄올로 환류 가열 추출하고; 추출된 용액을 회수하고; 원심분리하고; 상청액을 수집하고; 재결정화를 수행하여 총 플라바논 농축 부분을 얻고; 40-50℃에서 진공 건조시키고, 총 플라바논 함유량이 >80%인지를 확인하기 위하여 검출하여 생성된다.The total flavanone extract of the target dogwood crushed the dogwood; The ground dogwood was extracted by heating under reflux with 60% ethanol; Recover the extracted solution; Centrifugation; Collect the supernatant; Recrystallization is performed to obtain a total flavanone enriched portion; Vacuum dried at 40-50 ° C. and detected to produce a total flavanone content of> 80%.
실시예Example 2 2
주취 예방 및 숙취 해소 캡슐은 인동의 총 플라바논 추출물, 파키만의 총 플라바논 추출물 및 층층나무의 총 플라바논 추출물을 주성분으로서 포함하며, β-시클로덱스트린을 아주반트 성분으로서 포함하며; 하기 단계들을 통해 생성된다:Alcohol Prevention and Hangover Relief Capsules include the total flavanone extract of Phosphorus, the total flavanone extract of Pachyman and the total flavanone extract of Dogwood, and β-cyclodextrin as the adjuvant component; It is created through the following steps:
(1) 실시예 1에서 생성한 500 g의 인동의 총 플라바논 추출물, 500 g의 파키만의 총 플라바논 추출물 및 5,000 g의 층층나무의 총 플라바논 추출물을 계량하고, 분쇄하고, 60-메쉬 체로 체질하고; 4,000 g의 β-시클로덱스트린을 계량하고, 상기 물질을 균일하게 혼합하는 단계;(1) Weighing 500 g of phosphorus total flavanone extract, 500 g pachyman's total flavanone extract and 5,000 g of dogwood's total flavanone extract produced in Example 1, pulverized and 60-mesh Sifted through a sieve; Weighing 4,000 g of β-cyclodextrin and mixing the material uniformly;
(2) 3,000 ㎖의 물을 첨가하고, 반복적으로 제분하고, 물 함유량이 <5%가 될 때까지 40-50℃에서 진공 건조시키고, 분쇄하고, 60-메쉬 체로 체질하는 단계;(2) adding 3,000 ml of water, milling repeatedly, vacuum drying at 40-50 ° C. until the water content is <5%, grinding and sieving with a 60-mesh sieve;
(3) 살균을 실시한 후, 20-40% 습도의 환경 하에서 펠릿으로 만들어서 20-40 메쉬의 입자를 얻는 단계; 및(3) after sterilization, pelletizing in an environment of 20-40% humidity to obtain 20-40 mesh of particles; And
(4) 50% 이하의 습도를 갖는 환경 하에서 입자를 캡슐에 채워서 각각 0.5 g의 중량을 갖는 캡슐을 얻는 단계.(4) filling the capsules with the particles under an environment having a humidity of 50% or less to obtain capsules each having a weight of 0.5 g.
투여 방법 및 투여량: 경구 투여, 매회 2개의 캡슐, 음주 30 분 전 따뜻한 물과 함께 투여.Dosage method and dosage: Oral administration, 2 capsules each time, with warm water 30 minutes before drinking.
실시예Example 3 3
주취 예방 및 숙취 해소 지제는 층층나무의 총 플라바논 추출물을 주성분으로서 포함하며, β-시클로덱스트린, 말토덱스트린 및 스테비오사이드를 아주반트 성분으로서 포함하며; 하기 단계들을 통해 생성된다:Odor prevention and hangover aids include total flavanone extract of dogwood as a main component and β-cyclodextrin, maltodextrin and stevioside as adjuvant components; It is created through the following steps:
(1) 실시예 1에서 생성한 5,000 g의 층층나무의 총 플라바논 추출물을 계량하고, 5,000 g의 β-시클로덱스트린 및 5,000 g의 말토덱스트린을 계량하고, 상기 물질을 균일하게 혼합하는 단계;(1) weighing the total flavanone extract of 5,000 g of the dogwood produced in Example 1, weighing 5,000 g of β-cyclodextrin and 5,000 g of maltodextrin and mixing the material uniformly;
(2) 5,000 ㎖의 물을 첨가하고, 반복적으로 제분하고, 물 함유량이 <5%이 될 때까지 40-50℃에서 진공 건조시키고, 분쇄하고, 60-메쉬 체로 체질하는 단계;(2) adding 5,000 ml of water, milling repeatedly, vacuum drying at 40-50 ° C. until the water content is <5%, pulverizing and sieving with 60-mesh sieve;
(3) 1,000 g의 스테비오사이드를 첨가하고, 균일하게 혼합하고, 살균을 실시한 후 20-40% 습도를 갖는 환경 하에서 펠릿으로 만들어 20-40 메쉬의 입자를 얻는 단계; 및(3) adding 1,000 g of stevioside, mixing uniformly, and performing sterilization to pellet in an environment with 20-40% humidity to obtain 20-40 mesh of particles; And
(4) 50% 이하의 습도를 갖는 환경 하에서 입자를 주머니에 채워서 각각 2 g의 중량을 갖는 주머니에 넣은 지제를 얻는 단계.(4) packing the particles into a bag under an environment having a humidity of 50% or less to obtain a paper placed in a bag each having a weight of 2 g.
투여 방법 및 투여량: 경구 투여, 매회 2개의 주머니, 음주 30 분 전 또는 후에 (지제를 끓인 물에 용해시킨 후) 투여.Dosage method and dosage: Oral administration, two bags each time, 30 minutes before or after drinking (after dissolving the paper in boiled water).
실시예Example 4 4
주취 예방 및 숙취 해소 정제는 파키만의 총 플라바논 추출물 및 층층나무의 총 플라바논 추출물을 주성분으로서 포함하며, β-시클로덱스트린 및 말토덱스트린을 아주반트 성분으로서 포함하며; 하기 단계들을 통해 생성된다:Anti-Drinking and Hangover Refining Tablets include Pachyman's Total Flavanone Extract and Dogwood's Total Flavanone Extract as main components, and β-cyclodextrin and Maltodextrin as Adjuvant components; It is created through the following steps:
(1) 실시예 1에서 생성한 300 g의 파키만의 총 플라바논 추출물 및 2,500 g의 층층나무의 총 플라바논 추출물을 계량하고, 2,500 g의 β-시클로덱스트린 및 2,500 g의 말토덱스트린을 계량하고, 상기 물질을 균일하게 혼합하는 단계;(1) 300 g of Pachyman's total flavanone extract and 2,500 g of Dogwood's total flavanone extract produced in Example 1 were weighed, 2,500 g of β-cyclodextrin and 2,500 g of maltodextrin were weighed Uniformly mixing the material;
(2) 살균을 실시한 후, 20-40% 습도를 갖는 환경 하에서 펠릿으로 만들어 20-40 메쉬의 입자를 얻고; 정제로 만들어서 각각 0.3 g의 중량을 갖는 정제를 얻는 단계에 의하여 생성된다. (2) after sterilization, pelletized under an environment with 20-40% humidity to obtain 20-40 mesh of particles; Produced by the steps of obtaining tablets each having a weight of 0.3 g.
투여 방법 및 투여량: 경구 투여, 매회 2-3개의 정제, 음주 30 분 전 또는 후에 투여.Dosing method and dosage: Oral administration, 2-3 tablets each time, 30 minutes before or after drinking.
시험예Test Example 1 One
실시예Example 2에서 생성한 Generated in 2 주취Alcohol 예방 숙취 해소 캡슐의 Prevention hangover elimination capsule 효과에 대한 관찰Observation of the effect
캡슐을 30명의 지원자에 의하여 시험하였다. 그들에게 음주 30 분 전에 2개의 캡슐을 투여하고, 음주 후 그들의 현기증 및 주취 증상을 관찰하였다. 30명 지원자 전원은 캡슐이 효과적이며, 음주자의 주취를 야기하는 알콜의 양을 크게 증가시킬 수 있으며, 주취 및 주취에 의하여 야기되는 현기증 및 통제 불능의 행동 등과 같은 신체 불쾌감을 예방할 수 있다는 피드백을 제공하였다. 대표적인 예는 하기와 같다:Capsules were tested by 30 volunteers. They received two capsules 30 minutes before drinking and observed their dizziness and intoxication after drinking. All 30 volunteers provide feedback that capsules are effective, can significantly increase the amount of alcohol causing alcohol intoxication, and prevent physical discomfort, such as dizziness and uncontrollable behavior caused by alcohol and alcohol It was. Representative examples are as follows:
매우 소량의 맥주를 마신 후 일반적으로 현기증을 겪었던 40세 남성 지원자(센(Shen)이라는 성을 가짐)에게 음주 30 분 전에 2개의 캡슐을 투여하였으며, 100 g의 52% 백포도주를 마신 후 현기증을 느끼지 않았다.A 40-year-old male volunteer (having a surname, Sen), who had a dizziness after drinking a very small amount of beer, received two capsules 30 minutes before drinking and did not feel dizzy after drinking 100 g of 52% white wine. Did.
맥주 4병을 마신 후 일반적으로 현기증을 겪었던 22세 남성 지원자(푸(Fu)라는 성을 가짐)에게 음주 30 분 전에 2개의 캡슐을 투여하였으며, 맥주 7병을 마신 후 현기증을 느끼지 않았다.After drinking four bottles of beer, a 22-year-old male volunteer (having a surname named Fu), who was generally dizzy, received two capsules 30 minutes before drinking and did not feel dizzy after drinking seven bottles of beer.
시험예Test Example 2 2
실시예Example 3에서 생성한 Generated in 3 주취Alcohol 예방 숙취 해소 Prevention of hangover 지제의Paper 효과에 대한 관찰Observation of the effect
지제를 5명의 지원자에 의하여 시험하였다. 그들에게 음주에 의하여 유발되는 현기증을 느낀 후 2개의 지재 주머니를 투여하였으며, 현기증 증상에 대한 완화 효과를 관찰하였다. 지원자 5명 전원은 지제가 효과적이었으며, 현기증 증상을 완화시키며, 주취 시간을 단축시킬 수 있다는 피드백을 제공하였다.Papers were tested by five volunteers. After receiving dizziness caused by alcohol, they were given two paper bags, and the alleviation effect on dizziness symptoms was observed. All five volunteers provided feedback that the paper was effective, relieved dizziness, and reduced infusion time.
시험예Test Example 3 3
실시예Example 4에서 생성한 Generated in 4 주취Alcohol 예방 숙취 해소 정제의 Prevention hangover elimination tablet 효과에 대한 관찰Observation of the effect
캡슐을 16명의 지원자에게 시험하였다. 그들에게 음주 30 분 전 2 개의 캡슐을 투여하였으며, 그들의 음주 후 현기증 및 주취 증상을 관찰하였다. 그들 중에서, 15명의 지원자는 정제가 효과적이었으며, 음주자의 주취를 유발하는 알콜의 양을 크게 증가시킬 수 있으며, 주취 및 주취에 의하여 유발되는 현기증 및 통제 불능 등의 행동과 같은 신체 불쾌감을 예방할 수 있다는 피드백을 제공하였다. 대표적인 예는 하기와 같다:Capsules were tested on 16 volunteers. They received two capsules 30 minutes before drinking and observed dizziness and intoxication after their drinking. Among them, 15 volunteers found that tablets were effective, significantly increased the amount of alcohol causing alcohol intoxication, and prevented physical discomfort, such as dizziness and out of control behavior caused by alcohol and alcohol Feedback was provided. Representative examples are as follows:
일반적으로 술을 많이 마시며, 곧 현기증을 느끼는 31세의 남성 지원자(가오(Gao)라는 성을 가짐)에게 음주 30 분 전 2개의 정제를 투여하였으며, 100 g의 52% 백포도주를 마신 후 현기증을 느끼지 못하였다.In general, two 31-year-old male volunteers (who have sex with Gao) who received a lot of alcohol and soon became dizzy were given two tablets 30 minutes before drinking and dizziness after drinking 100 g of 52% white wine. I didn't feel it.
백포도주는 전혀 마시지 않으며, 많아야 맥주 1 병을 마신 후 일반적으로 현기증을 겪었던 36세의 남성 지원자(장(Zhang)이라는 성을 가짐)에게 음주 30 분 전 2개의 정제를 투여하였으며, 100 g의 52% 백포도주를 마신 후 현기증을 느끼지 않았다.White wine was not drunk at all and was given two tablets 30 minutes before drinking alcohol to a 36-year-old male volunteer (whose name was Zhang) who generally had dizziness after drinking a bottle of beer at most, 52% of 100 g After drinking white wine did not feel dizzy.
Claims (7)
인동, 파키만 및 층층나무를 분쇄하고; 분쇄한 생성물을 물 또는 70% 미만의 농도인 에탄올로 각각 추출하며; 추출된 용액을 회수하고; 원심분리하고; 추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조시키고; 각각의 추출물의 함유량이 요건을 충족하는지를 확인하기 위하여 검출하는 방법에 의하여 제조되는, 주취 예방 및 숙취 해소 조성물.The total flavanone extract of the phosphorus, the total flavanone extract of pakiman and the total flavanone extract of the dogwood,
Grinding copper, pachyman and dogwood; The milled products were each extracted with water or ethanol at a concentration of less than 70%; Recover the extracted solution; Centrifugation; Extraction, macroporous resin column chromatography or recrystallization is carried out; Vacuum dried at 40-50 ° C .; The anti-drinking and hangover composition produced by the method of detecting to confirm that the content of each extract meets the requirements.
(1) 인동, 파키만 및 층층나무를 분쇄하고; 분쇄된 생성물을 물 또는 70% 미만의 농도인 에탄올로 각각 추출하고; 추출된 용액을 회수하고; 원심분리하고; 추출, 거대다공성 수지 컬럼 크로마토그래피 또는 재결정화를 수행하고; 40-50℃에서 진공 건조시키고; 각각의 추출물의 함유량이 요건을 충족하는지를 확인하기 위하여 검출하여 인동의 총 플라바논 추출물, 파키만의 총 플라바논 추출물 및 층층나무의 총 플라바논 추출물을 얻고; 각각의 추출물을 분쇄하고, 60-메쉬 체로 체질하는 단계;
(2) 중량부로 인동의 총 플라바논 추출물 0-40, 파키만의 총 플라바논 추출물 0-40 및 층층나무의 총 플라바논 추출물 20-100을 계량하고, 이를 균일하게 혼합하여 주성분을 얻는 단계;
(3) 중량부로 β-시클로덱스트린 0-100 및 말토덱스트린 0-100을 계량하고, 이를 상기 주성분과 균일하게 혼합하고, 총 중량을 기준으로 하여 10-50% 물을 첨가하고, 반복적으로 제분, 진공 건조, 분쇄 및 60-메쉬 체를 사용한 체질을 실시하는 단계; 및
(4) 0-20 중량부의 스테비오사이드를 첨가하고, 균일하게 혼합, 살균, 펠릿화하고, 캡슐, 정제 또는 지제(electuary)로의 제조 단계를 포함하는, 제조 방법.In the manufacturing method of the alcohol prevention and hangover relief composition,
(1) grinding copper, pachyman and dogwood; The milled product was each extracted with water or ethanol at a concentration of less than 70%; Recover the extracted solution; Centrifugation; Extraction, macroporous resin column chromatography or recrystallization is carried out; Vacuum dried at 40-50 ° C .; Detecting to obtain that the content of each extract meets the requirements to obtain a total flavanone extract of phosphorus, a total flavanone extract of pakiman and a total flavanone extract of dogwood; Milling each extract and sieving with a 60-mesh sieve;
(2) weighing the total flavanone extract 0-40 of Phosphorus, the total flavanone extract 0-40 of Pakiman and the total flavanone extract 20-100 of the dogwood by weight, and uniformly mixing them to obtain a main component;
(3) weighing β-cyclodextrin 0-100 and maltodextrin 0-100 by weight, mixing it uniformly with the main ingredients, adding 10-50% water based on the total weight, repeatedly milling, Performing vacuum drying, grinding and sieving using a 60-mesh sieve; And
(4) 0-20 parts by weight of steviosides are added, uniformly mixed, sterilized, pelletized, and prepared into capsules, tablets or electuary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180078663A KR20200005217A (en) | 2018-07-06 | 2018-07-06 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180078663A KR20200005217A (en) | 2018-07-06 | 2018-07-06 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200005217A true KR20200005217A (en) | 2020-01-15 |
Family
ID=69156642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180078663A KR20200005217A (en) | 2018-07-06 | 2018-07-06 | An anti-drunkenness and hangover-alleviating composition and its preparation method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20200005217A (en) |
-
2018
- 2018-07-06 KR KR1020180078663A patent/KR20200005217A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hwang et al. | Antioxidant and anti-inflammatory activities of broccoli florets in LPS-stimulated RAW 264.7 cells | |
Chen et al. | Supplementation of Eurycoma longifolia Jack extract for 6 weeks does not affect urinary testosterone: Epitestosterone ratio, liver and renal functions in male recreational athletes | |
Yuan et al. | Combination of selenium‐enriched green tea polysaccharides and Huo‐ji polysaccharides synergistically enhances antioxidant and immune activity in mice | |
JP4788994B2 (en) | Functional food and drink | |
Kim et al. | Chemical and biological properties of puffed Dendrobium officinale extracts: Evaluation of antioxidant and anti-fatigue activities | |
CN104815138A (en) | Immature bitter orange extract, preparation and application | |
KR20200009824A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
Ibrahim et al. | Effect of extraction on phenoilc content, silymarin and antiradical activities of artichoke leaves and roots | |
KR20200005217A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
Nematbakhsh et al. | The effects of unripe grape extract on systemic blood pressure, nitric oxide production, and response to angiotensin II administration | |
DE102018117603A1 (en) | Anti-drunk and hangover relief composition and method of manufacture | |
Lee et al. | Physiochemical properties and neuroprotective function of Korean major yuzu varieties | |
KR20200020287A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
KR20200017870A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
Sarwar et al. | Herbal teas: The benefit: risk ratio | |
Wang et al. | Antioxidative effect of large molecular polymeric pigments extracted from zijuan pu-erh tea in vitro and in vivo | |
KR20230058792A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
KR20200022771A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
JP2020007250A (en) | Anti-drunkenness and hangover-mitigating composition, and method of preparing the same | |
KR20160059743A (en) | Composition for the immunity stimulatory activity comprising orostachys japonicus A. berger water extract | |
JP2009269834A (en) | Bone resorption inhibitor, food and drink for bone resorption inhibition and quasi drug | |
KR101342570B1 (en) | Functional foods containing red ginseng and walnut | |
KR20200004196A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
KR20200032798A (en) | An anti-drunkenness and hangover-alleviating composition and its preparation method | |
CN101301356B (en) | Use of Schisandra chinensis extract in treating alcohol liver |